| 1 |
Tian W, Hu W, Shi X, Liu P, Ma X, Zhao W, Qu L, Zhang S, Shi W, Liu A, Cao J. Comprehensive genomic profile of cholangiocarcinomas in China. Oncol Lett 2020;19:3101-10. [PMID: 32256810 DOI: 10.3892/ol.2020.11429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 2 |
Miranda R, Silva T, Forones N. High-resolution melting for detecting KRAS mutations in colorectal cancer. biom rep 2019. [DOI: 10.3892/br.2019.1254] [Reference Citation Analysis]
|
| 3 |
Staden RS, Ilie-mihai R, Gugoasa LA, Stanciu-gavan C. Pattern Recognition of p53 and KRAS in Whole Blood Samples. J Electrochem Soc 2019;166:B183-6. [DOI: 10.1149/2.0201904jes] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Al-ogaidi AJM, Stefan-van Staden R, Gugoasa LA, Rosu M, Socaci C. Electrochemical Determination of the KRAS Genetic Marker for Colon Cancer with Modified Graphete and Graphene Paste Electrodes. Analytical Letters 2018;51:2822-34. [DOI: 10.1080/00032719.2018.1453516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 5 |
Bennani B, Gilles S, Fina F, Nanni I, Ibrahimi SA, Riffi AA, Nejjari C, Benajeh D, Abkari ME, Martin P, Ouafik L. Mutation Analysis of Braf Exon 15 and Kras Codons 12 and 13 in Moroccan Patients with Colorectal Cancer. Int J Biol Markers 2010;25:179-84. [DOI: 10.5301/jbm.2010.6091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 6 |
Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Mol Diagn 2017;19:187-225. [PMID: 28185757 DOI: 10.1016/j.jmoldx.2016.11.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 7 |
Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer. Am J Clin Pathol 2017;147:221-60. [PMID: 28165529 DOI: 10.1093/ajcp/aqw209] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 8 |
Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol. 2017;35:1453-1486. [PMID: 28165299 DOI: 10.1200/jco.2016.71.9807] [Cited by in Crossref: 198] [Cited by in F6Publishing: 211] [Article Influence: 33.0] [Reference Citation Analysis]
|
| 9 |
Siravegna G, Bardelli A. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients. Mol Oncol. 2016;10:475-480. [PMID: 26774880 DOI: 10.1016/j.molonc.2015.12.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 10 |
Kriegsmann M, Arens N, Endris V, Weichert W, Kriegsmann J. Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique. Diagn Pathol 2015;10:132. [PMID: 26220423 DOI: 10.1186/s13000-015-0364-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 11 |
Xie G, Xie F, Wu P, Yuan X, Ma Y, Xu Y, Li L, Xu L, Yang M, Shen L. The mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order. J Exp Clin Cancer Res 2015;34:63. [PMID: 26081767 DOI: 10.1186/s13046-015-0179-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 12 |
Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu A, Lauricella C, Lamba S, Hobor S, Avallone A, Valtorta E, Rospo G, Medico E, Motta V, Antoniotti C, Tatangelo F, Bellosillo B, Veronese S, Budillon A, Montagut C, Racca P, Marsoni S, Falcone A, Corcoran RB, Di Nicolantonio F, Loupakis F, Siena S, Sartore-Bianchi A, Bardelli A. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21:795-801. [PMID: 26030179 DOI: 10.1038/nm.3870] [Cited by in Crossref: 572] [Cited by in F6Publishing: 601] [Article Influence: 71.5] [Reference Citation Analysis]
|
| 13 |
Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 14 |
Liu YP, Wu HY, Yang X, Xu HQ, Chen D, Huang Q, Fu WL. Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis. Sci Rep 2014;4:7521. [PMID: 25515911 DOI: 10.1038/srep07521] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 15 |
Herreros-Villanueva M, Chen CC, Yuan SS, Liu TC, Er TK. KRAS mutations: analytical considerations. Clin Chim Acta 2014;431:211-20. [PMID: 24534449 DOI: 10.1016/j.cca.2014.01.049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 16 |
Pasic M, Hojilla C, Yousef GM. Polymerase Chain Reaction. Molecular Testing in Cancer 2014. [DOI: 10.1007/978-1-4899-8050-2_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 17 |
Malapelle U, Carlomagno C, de Luca C, Bellevicine C, Troncone G. KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond. J Clin Pathol 2013;67:1-9. [DOI: 10.1136/jclinpath-2013-201835] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Brotto K, Malisic E, Cavic M, Krivokuca A, Jankovic R. The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in Serbian colorectal cancer patients. Dig Dis Sci 2013;58:998-1003. [PMID: 23108567 DOI: 10.1007/s10620-012-2469-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 19 |
Abd El Kader Y, Emera G, Safwat E, Kassem HA, Kassem NM. The KRAS StripAssay for detection of KRAS mutation in Egyptian patients with colorectal cancer (CRC): a pilot study. J Egypt Natl Canc Inst 2013;25:37-41. [PMID: 23499205 DOI: 10.1016/j.jnci.2012.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 20 |
Ozen F, Ozdemir S, Zemheri E, Hacimuto G, Silan F, Ozdemir O. The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population. Genet Test Mol Biomarkers 2013;17:135-9. [PMID: 23297805 DOI: 10.1089/gtmb.2012.0290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 21 |
Myers MB, Wang Y, McKim KL, Parsons BL. Hotspot oncomutations: implications for personalized cancer treatment. Expert Rev Mol Diagn 2012;12:603-20. [PMID: 22845481 DOI: 10.1586/erm.12.51] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 22 |
Chen J, Ye Y, Sun H, Shi G. Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis. Cancer Chemother Pharmacol 2013;71:265-72. [PMID: 23090619 DOI: 10.1007/s00280-012-2005-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 23 |
Malapelle U, Carlomagno C, Salatiello M, De Stefano A, De Luca C, Bianco R, Marciano R, Cimminiello C, Bellevicine C, De Placido S, Troncone G. KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer. Br J Cancer 2012;107:626-31. [PMID: 22805329 DOI: 10.1038/bjc.2012.275] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 24 |
Nowak F, Soria J, Calvo F. Tumour molecular profiling for deciding therapy—the French initiative. Nat Rev Clin Oncol 2012;9:479-86. [DOI: 10.1038/nrclinonc.2012.42] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 25 |
Tu JH, Yu YH. New progress in understanding implications of gene mutations for targeted therapies in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2012; 20(16): 1447-1452 [DOI: 10.11569/wcjd.v20.i16.1447] [Reference Citation Analysis]
|
| 26 |
Krol LC, ‘t Hart NA, Methorst N, Knol AJ, Prinsen C, Boers JE. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma. Eur J Cancer. 2012;48:1108-1115. [PMID: 22446020 DOI: 10.1016/j.ejca.2012.02.054] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 27 |
Farrugia A, Keyser C, Ludes B. Detection of genetic variation in KCNQ1 gene by high-resolution melting analysis in a prospective-based series of postmortem negative sudden death: comparison of results obtained in fresh frozen and formalin-fixed paraffin-embedded tissues. Int J Legal Med 2012;126:649-57. [DOI: 10.1007/s00414-012-0688-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 28 |
Ibrahim AE, Arends MJ. Molecular typing of colorectal cancer: applications in diagnosis and treatment. Diagnostic Histopathology 2012;18:70-80. [DOI: 10.1016/j.mpdhp.2011.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Li BS, Wang XY, Ma FL, Jiang B, Song XX, Xu AG. Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta analysis. PLoS One 2011;6:e28078. [PMID: 22194806 DOI: 10.1371/journal.pone.0028078] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 30 |
Macedo MP, Andrade Lde B, Coudry R, Crespo R, Gomes M, Lisboa BC, Aguiar S Jr, Soares FA, Carraro DM, Cunha IW. Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports. Int J Colorectal Dis 2011;26:1241-8. [PMID: 21603900 DOI: 10.1007/s00384-011-1238-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 31 |
Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M, Carballo M. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC Cancer 2011;11:406. [PMID: 21943394 DOI: 10.1186/1471-2407-11-406] [Cited by in Crossref: 65] [Cited by in F6Publishing: 75] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 32 |
Magnin S, Viel E, Baraquin A, Valmary-Degano S, Kantelip B, Pretet JL, Mougin C, Bigand M, Girardo B, Borg C, Ferrand C. A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers. J Mol Diagn 2011;13:485-92. [PMID: 21742054 DOI: 10.1016/j.jmoldx.2011.05.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 33 |
Fariña Sarasqueta A, Moerland E, de Bruyne H, de Graaf H, Vrancken T, van Lijnschoten G, van den Brule AJ. SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics. J Mol Diagn 2011;13:199-205. [PMID: 21354055 DOI: 10.1016/j.jmoldx.2010.10.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 34 |
Solassol J, Ramos J, Crapez E, Saifi M, Mangé A, Vianès E, Lamy PJ, Costes V, Maudelonde T. KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues. Int J Mol Sci 2011;12:3191-204. [PMID: 21686179 DOI: 10.3390/ijms12053191] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 35 |
Kitano S, Nakayama M, Yamane A, Tsukahara Y, Amano M. Detection of DNA mutations by fluorescence resonance energy transfer-based preferential homoduplex formation assay. Analytical Biochemistry 2011;408:197-205. [DOI: 10.1016/j.ab.2010.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 36 |
Dotti I, Nardon E, Pracella D, Bonin S. Quantitative Real-Time RT-PCR. Guidelines for Molecular Analysis in Archive Tissues 2011. [DOI: 10.1007/978-3-642-17890-0_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 37 |
De Miglio MR, Mura A, Uras MG, Manca A, Contini M, Murgia L, Zinellu A, Sotgia S, Carru C, Massarelli G, Cossu-rocca P. High Sensitivity of Reverse-hybridization Methodology in the Detection of KRAS Mutations from Formalin-fixed Paraffin-embedded Colorectal Cancer Samples: . Diagnostic Molecular Pathology 2010;19:201-8. [DOI: 10.1097/pdm.0b013e3181db67d5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 38 |
Kristensen LS, Daugaard IL, Christensen M, Hamilton-Dutoit S, Hager H, Hansen LL. Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products. Hum Mutat 2010;31:1366-73. [PMID: 20848649 DOI: 10.1002/humu.21358] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 39 |
López-Villar I, Ayala R, Wesselink J, Morillas JD, López E, Marín JC, Díaz-Tasende J, González S, Robles L, Martínez-López J. Simplifying the detection of MUTYH mutations by high resolution melting analysis. BMC Cancer 2010;10:408. [PMID: 20687945 DOI: 10.1186/1471-2407-10-408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
